

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
He lāʻau lapaʻau kūikawā ʻo Rozanolixizumab i hoʻolālā ʻia e kōkua i ka poʻe me kekahi mau maʻi autoimmune kahi e hoʻouka hewa ai ka ʻōnaehana pale o ke kino i nā ʻiʻo olakino. Hana kēia lapaʻau i ka pale ʻana i nā protein ʻōnaehana pale kūikawā e kōkua i ka nāwaliwali o nā ʻiʻo a me nā hōʻailona ʻē aʻe i nā maʻi e like me ka myasthenia gravis.
Inā ua kau ʻia kēia lāʻau lapaʻau iā ʻoe a i ʻole kekahi āu e mālama ai, he mau nīnau paha kāu e pili ana i ke ʻano o kāna hana, ka mea e manaʻo ai, a pehea e hoʻohana ai me ka palekana. E hele kākou i nā mea a pau e pono ai ʻoe e ʻike e pili ana i kēia koho lapaʻau ma ke ʻano e maʻalahi a maopopo.
ʻO Rozanolixizumab he lāʻau lapaʻau i kau ʻia e pili ana i kahi papa o nā lāʻau i kapa ʻia he monoclonal antibodies. E noʻonoʻo iā ia he kī kikoʻī loa e kūpono i nā laka kūikawā i loko o kāu ʻōnaehana pale e kōkua i ka hōʻemi ʻana i ka hana pale ʻole.
Hāʻawi ʻia kēia lāʻau lapaʻau ma ke ʻano he injection ma lalo o ka ʻili, e like me ke ʻano o ka poʻe me ka maʻi diabetes e hāʻawi iā lākou iho i nā pana insulin. ʻO ka
ʻO ka poʻe me kēia maʻi e ʻike pinepine i ka nāwaliwali o nā ʻiʻo e ʻoi aku ka maikaʻi me ka hana a hoʻomaikaʻi me ka hoʻomaha. ʻO nā hōʻailona maʻamau e komo pū ana me ka hāʻule ʻana o nā lihilihi, ka paʻakikī i ka nau ʻana a i ʻole ka ʻai ʻana, ka pilikia i ka ʻōlelo maopopo ʻana, a me ka nāwaliwali o nā lima a me nā wāwae.
Hiki i kāu kauka ke ʻōlelo aku i kēia lāʻau lapaʻau inā ʻaʻole i hāʻawi nā lāʻau lapaʻau ʻē aʻe i ka hōʻoluʻolu lawa a i ʻole ke ʻike nei ʻoe i nā hōʻailona nui e pili ana i kou ola i kēlā me kēia lā. He mea kōkua nui ia no ka poʻe i loaʻa nā antibodies i loko o ko lākou koko e kōkua ana i ka nāwaliwali o nā ʻiʻo.
Hana ʻo Rozanolixizumab ma ka ʻimi ʻana i kahi protein kikoʻī i loko o kāu ʻōnaehana pale, i kapa ʻia ʻo ka neonatal Fc receptor. Kōkua maʻamau kēia protein i ka hana hou ʻana i nā antibodies i loko o kou kino, akā i ka myasthenia gravis, hiki iā ia ke kōkua i ka mālama ʻana i nā antibodies ʻino e hoʻouka i kāu mau pilina ʻiʻo.
Ma ka ālai ʻana i kēia protein, kōkua ka lāʻau lapaʻau i ka hōʻemi ʻana i ka helu o nā antibodies ʻino e holo ana i loko o kou koko. Hiki i kēia ke alakaʻi i ka hoʻomaikaʻi ʻana i ka ikaika o nā ʻiʻo a me ka hōʻemi ʻana i ka luhi i ka manawa.
Ua manaʻo ʻia he lāʻau lapaʻau ikaika i kaulike e hana ana ma kahi pae kikoʻī loa i loko o kāu ʻōnaehana pale. ʻAʻole ia e kāohi i kāu ʻōnaehana pale holoʻokoʻa e like me kekahi mau lāʻau lapaʻau ʻē aʻe, he mea maikaʻi ia no ka mālama ʻana i kou hiki ke hakakā i nā maʻi.
Hāʻawi ʻia ʻo Rozanolixizumab ma ke ʻano he injection subcutaneous, ʻo ia hoʻi, komo ia i loko o ka ʻiʻo momona ma lalo pono o kou ʻili. E aʻo kāu mea mālama ola iā ʻoe a i ʻole kekahi lālā o ka ʻohana pehea e hāʻawi palekana ai i kēia mau injections ma ka home.
Hele mai ka lāʻau lapaʻau i loko o nā syringes i hoʻopiha mua ʻia a i ʻole nā mea hoʻoheheʻe auto e maʻalahi ai ke kaʻina hana. E hoʻokomo maʻamau ʻoe iā ia i nā wahi e like me kou ʻūhā, ka lima luna, a i ʻole ka ʻōpū, e hoʻololi ana ma waena o nā wahi like ʻole e pale ai i ka huhū o ka ʻili.
ʻAʻole pono ʻoe e lawe i kēia lāʻau me ka meaʻai a i ʻole ka waiū no ka mea he pahu ia ma mua o ka pila. Eia naʻe, he mea nui e ʻae i ka lāʻau lapaʻau e hiki i ka mahana o ka lumi ma mua o ka hoʻokomo ʻana, no ka mea, hiki i ka lāʻau lapaʻau anu ke hōʻoluʻolu.
E mālama i ka lāʻau lapaʻau i loko o kāu pahu hau a hiki i kou mākaukau e hoʻohana. Mai lulu i ka lāʻau lapaʻau, a e nānā mau i ka maopopo a me ka ʻole o ka wai ma mua o ka hoʻokomo ʻana.
ʻO ka lōʻihi o ka mālama ʻana me ka rozanolixizumab e ʻokoʻa mai kēlā kanaka i kēia kanaka a pili i ka maikaʻi o kāu pane ʻana i ka lāʻau lapaʻau. E nānā kāu kauka i kāu mau hōʻailona a hoʻoponopono i kāu hoʻolālā lapaʻau e pili ana i kāu mau pono pilikino.
Pono paha kekahi poʻe i kēia lāʻau lapaʻau no kekahi mau mahina, aʻo nā mea ʻē aʻe e hoʻohana paha ia no nā manawa lōʻihi. E loiloi mau kāu mea mālama ola inā e kōkua ana ka lāʻau lapaʻau i kāu mau hōʻailona a inā he koho kūpono ia nāu.
He mea nui e hoʻomau i ka lawe ʻana i ka lāʻau lapaʻau e like me ke kau ʻana, ʻoiai inā hoʻomaka ʻoe e maikaʻi. ʻO ka hoʻōki koke ʻana e hiki ke hoʻihoʻi a hōʻino paha i kāu mau hōʻailona.
E like me nā lāʻau lapaʻau a pau, hiki i ka rozanolixizumab ke hana i nā hopena ʻaoʻao, ʻoiai ʻaʻole ʻike nā mea a pau iā lākou. ʻO ka hoʻomaopopo ʻana i ka mea e nānā ai hiki ke kōkua iā ʻoe e mākaukau a hilinaʻi i kāu lapaʻau.
He maʻalahi a hiki ke mālama ʻia nā hopena ʻaoʻao maʻamau. Hiki i kēia ke komo i nā hopena ma kahi o ka pūnaewele injection e like me ka ʻulaʻula, ka pehu, a i ʻole ka ʻeha maʻalahi kahi āu i hāʻawi ai i ka pana.
Eia nā hopena ʻaoʻao maʻamau āu e ʻike ai:
E maikaʻi pinepine kēia mau hopena ʻaoʻao maʻamau i ka wā e hoʻoponopono ai kou kino i ka lāʻau lapaʻau, a ʻike ka hapa nui o nā kānaka he mea hiki ke mālama ʻia me nā hana maʻalahi e like me ka hoʻopili ʻana i ka hau i nā wahi injection a i ʻole ka lawe ʻana i nā mea hōʻeha ʻeha ma luna o ka pāʻai e like me ka ʻōlelo a kā lākou kauka.
Aia kekahi mau hopena ʻaoʻao liʻiliʻi akā ʻoi aku ka koʻikoʻi e pono ai ka lāʻau lapaʻau koke. ʻOiai he kakaikahi kēia, he mea nui e ʻike iā lākou i hiki iā ʻoe ke ʻimi i ke kōkua inā pono.
E hoʻokaʻaʻike koke i kāu mea mālama ola inā ʻike ʻoe:
E hoʻomanaʻo ua kauoha kāu hui mālama ola i kēia lāʻau lapaʻau no ka mea manaʻo lākou e ʻoi aku ka maikaʻi ma mua o nā pilikia no kāu kūlana kikoʻī. E nānā pono lākou iā ʻoe, ʻoiai i ka wā e hoʻomaka mua ai ʻoe i ka lāʻau lapaʻau.
ʻAʻole kūpono ʻo Rozanolixizumab no nā mea a pau, a e nānā pono kāu kauka i kāu moʻolelo olakino ma mua o ke kau ʻana. Aia kekahi mau kūlana i ka wā e palekana ʻole ai kēia lāʻau lapaʻau a i ʻole kūpono iā ʻoe.
ʻAʻole pono ʻoe e lawe iā rozanolixizumab inā loaʻa iā ʻoe kahi hopena maʻi maʻi koʻikoʻi i kēia lāʻau lapaʻau a i ʻole kekahi o kāna mau meaʻai. E kūkākūkā kāu kauka i kāu moʻolelo maʻi maʻi i kāu kūkākūkā.
Pono paha ka poʻe me kekahi mau maʻi olakino i ka nānā ʻana kūikawā a i ʻole ʻaʻole paha he mau moho maikaʻi no kēia lāʻau lapaʻau. E noʻonoʻo pono kāu mea mālama ola i kēia mau mea:
Inā hāpai ʻoe a ke hoʻāʻo nei e hāpai, e kūkākūkā me kāu kauka i kēia manawa. ʻAʻole i ʻike piha ʻia nā hopena o ka rozanolixizumab i ka hāpai ʻana, no laila pono e loiloi kāu mea mālama ola i nā pōmaikaʻi a me nā pilikia me ka mālama pono no kou kūlana.
Hoʻolaha ʻia ʻo Rozanolixizumab ma lalo o ka inoa inoa Rystiggo. ʻO kēia ka inoa āu e ʻike ai ma kāu lepili kauoha a me ka ʻeke lāʻau.
Ke kamaʻilio me kāu kauka lāʻau a i ʻole mea mālama ola, hiki iā ʻoe ke kuhikuhi iā ia ma kekahi inoa. He lāʻau lapaʻau like lākou, e like me ka ibuprofen a me Advil he lāʻau like me nā inoa like ʻole.
E hōʻoia mau e loaʻa ana iā ʻoe ka lāʻau lapaʻau kūpono ma ka nānā ʻana i ka inoa generic (rozanolixizumab) a me ka inoa inoa (Rystiggo) ma kāu kauoha a me ka ʻeke lāʻau.
Inā ʻaʻole kūpono ka rozanolixizumab iā ʻoe a ʻaʻole hāʻawi i ka hōʻoluʻolu kūpono, aia nā koho lapaʻau ʻē aʻe no ka myasthenia gravis. Hiki i kāu kauka ke kōkua iā ʻoe e ʻimi i kēia mau koho ʻē aʻe e pili ana i kāu mau pono a me ka mōʻaukala olakino.
ʻO nā lāʻau lapaʻau ʻē aʻe i hoʻohana ʻia e mālama i ka myasthenia gravis me nā mea hoʻopaʻa cholinesterase e like me ka pyridostigmine, e kōkua ana i ka hoʻomaikaʻi ʻana i ke kamaʻilio ʻana o ke aʻalolo-muscle. Hiki nō hoʻi nā lāʻau immunosuppressive e like me ka prednisone a i ʻole azathioprine.
No kekahi poʻe, hiki ke ʻōlelo ʻia nā lāʻau lapaʻau e like me ka hoʻololi plasma a i ʻole intravenous immunoglobulin, ʻoi aku hoʻi i ka wā o nā hōʻailona koʻikoʻi. E hana pū kāu mea mālama ola me ʻoe e ʻimi i ke ala lapaʻau maikaʻi loa no kou kūlana.
Aia nō i kou kūlana, nā hōʻailona, a me ke ʻano o kou pane ʻana i nā lāʻau lapaʻau like ʻole inā ua ʻoi aku ka maikaʻi o rozanolixizumab ma mua o nā lāʻau lapaʻau ʻē aʻe. He ʻike kū hoʻokahi ko kēlā me kēia kanaka me ka myasthenia gravis, a ʻokoʻa ka mea e hana maikaʻi loa mai kēlā kanaka i kēia kanaka.
Hāʻawi ʻo Rozanolixizumab i kekahi mau pōmaikaʻi, e like me ka ʻoi aku o ka pahuhopu ma mua o nā lāʻau lapaʻau immunosuppressive ākea, ʻo ia hoʻi he liʻiliʻi nā hopena i kāu ʻōnaehana pale. Hoʻolālā ʻia nō hoʻi no nā poʻe me ka antibody-positive myasthenia gravis.
Eia naʻe, ua hoʻohana ʻia nā lāʻau lapaʻau ʻē aʻe e like me ka pyridostigmine no nā makahiki he nui a hana maikaʻi no nā poʻe he nui. ʻO kekahi poʻe maʻi e hana maikaʻi loa me ka hui pū ʻana o nā lāʻau lapaʻau ma mua o ka hilinaʻi ʻana i hoʻokahi lāʻau lapaʻau.
E noʻonoʻo kāu kauka i nā mea e like me ke koʻikoʻi o kāu mau hōʻailona, nā maʻi olakino ʻē aʻe, ke ʻano o ke ola, a me nā makemake lapaʻau i ka wā e ʻōlelo ai i ke ala maikaʻi loa no ʻoe.
Inā he mau maʻi autoimmune ʻē aʻe kāu ma waho aʻe o ka myasthenia gravis, pono i kāu kauka ke loiloi pono inā palekana ʻo rozanolixizumab iā ʻoe. Hoʻopilikia ka lāʻau lapaʻau i kekahi mau ʻano o kāu ʻōnaehana pale, hiki ke launa pū me nā maʻi autoimmune ʻē aʻe.
E nānā kāu mea mālama ola i kāu mōʻaukala olakino piha a hiki ke kūkākūkā me nā loea ʻē aʻe e hōʻoia ʻaʻole e keakea kēia lāʻau lapaʻau i nā lāʻau lapaʻau no kāu mau maʻi ʻē aʻe. E nānā pū lākou iā ʻoe inā he nui kāu mau maʻi autoimmune.
Inā ua hoʻokomo hewa ʻoe i ka rozanolixizumab ʻoi aku ma mua o ka mea i kauoha ʻia, e kelepona koke i kāu mea mālama ola a i ʻole ke kikowaena hoʻomalu lāʻau make. Mai kali e ʻike inā e ulu ana nā hōʻailona, no ka mea, ʻoi aku ka maikaʻi o ka ʻimi ʻana i ke alakaʻi koke.
ʻOiai ʻaʻole maʻamau nā hopena overdose koʻikoʻi, hiki i ka hoʻohana ʻana i ka lāʻau lapaʻau nui ke hoʻonui i kou pilikia o nā hopena ʻaoʻao a i ʻole ka hoʻopaʻa ʻana i ka ʻōnaehana pale. Hiki i kāu kauka ke makemake e nānā pono iā ʻoe a i ʻole e hoʻoponopono i kāu mahele i hoʻonohonoho ʻia e hiki mai ana.
E mālama i ka ʻeke lāʻau lapaʻau me ʻoe ke kelepona ʻoe, no ka mea, e kōkua kēia ʻike i nā mea mālama ola e hāʻawi iā ʻoe i ka ʻōlelo aʻo maikaʻi loa no kou kūlana.
Inā ua hala ʻoe i kahi mahele i hoʻonohonoho ʻia o ka rozanolixizumab, e kelepona i kāu mea mālama ola no ke alakaʻi ʻana i ka manawa e lawe ai i kāu injection e hiki mai ana. Mai ho'āʻo e pāpālua i nā mahele e hoʻoponopono ai i ka mea i hala.
E hilinaʻi ka manawa o kāu mahele e hiki mai ana i ka lōʻihi o ka manawa mai kou hala ʻana i kāu injection i hoʻonohonoho ʻia. Hiki i kāu kauka ke ʻōlelo e lawe i ka mahele i hala i ka hikiwawe a i ʻole e kali a hiki i kou manawa i hoʻonohonoho ʻia e hiki mai ana.
E hoʻāʻo e hoʻokumu i kahi hana maʻamau e kōkua iā ʻoe e hoʻomanaʻo i kāu mau injections, e like me ka hoʻohana ʻana i kahi hoʻomanaʻo kalena a i ʻole ka hoʻonohonoho ʻana i kahi alarm ma kāu kelepona. Kōkua ka hoʻopaʻa ʻana i ka lāʻau lapaʻau i ka mālama ʻana i nā pae paʻa o ka lāʻau lapaʻau i loko o kāu ʻōnaehana.
Mai hooki i ka lawe ʻana iā rozanolixizumab me ka ʻole e kūkākūkā mua me kāu mea mālama ola. ʻOiai inā ʻoe e manaʻo maikaʻi ana, hiki i ka hooki ʻana i ka hopena ke hoʻi mai a i ʻole e hōʻino i kāu mau hōʻailona myasthenia gravis.
E loiloi mau kāu kauka i ka maikaʻi o ka hana ʻana o ka lāʻau lapaʻau iā ʻoe a inā ʻo ia nō ka koho lapaʻau maikaʻi loa. Hiki iā lākou ke noʻonoʻo e hōʻemi i ka mahele a i ʻole e hooki i ka lāʻau lapaʻau inā ua mālama maikaʻi ʻia kāu mau hōʻailona a paʻa.
ʻO ka hoʻoholo e hooki i ka lapaʻau e pili ana i ka noʻonoʻo pono ʻana i kāu mau hōʻailona i kēia manawa, pehea ka lōʻihi o kou paʻa ʻana, a me nā lapaʻau ʻē aʻe āu e pono ai. E hana kāu mea mālama ola i kahi hoʻolālā palekana a maikaʻi loa no kāu kūlana kikoʻī.
Hiki iā ʻoe ke loaʻa ka hapa nui o nā lāʻau lapaʻau ʻoiai e lawe ana iā rozanolixizumab, akā pono ʻoe e pale i nā lāʻau lapaʻau ola i ka wā o ka lapaʻau. Aia nā lāʻau lapaʻau ola i nā mana nāwaliwali akā ola o nā maʻi a i ʻole nā bacteria, hiki ke hoʻopilikia i ka wā e hoʻololi ʻia ai kāu ʻōnaehana pale e ka lāʻau lapaʻau.
ʻO nā laʻana o nā lāʻau lapaʻau ola e komo pū ana i ka lāʻau lapaʻau flu nasal, ka lāʻau lapaʻau MMR, a me ka lāʻau lapaʻau yellow fever. Eia naʻe, ʻo nā lāʻau lapaʻau i hoʻopau ʻia e like me ka pana flu, nā lāʻau lapaʻau COVID-19, a me ka hapa nui o nā lāʻau lapaʻau maʻamau ʻē aʻe he palekana ke loaʻa.
E hoʻomaopopo mau i kekahi mea mālama ola e hāʻawi ana iā ʻoe i nā lāʻau lapaʻau e lawe ana ʻoe iā rozanolixizumab. Hiki iā lākou ke kōkua i ka hoʻoholo ʻana i ka manawa maikaʻi loa a me ke ʻano o nā lāʻau lapaʻau no kou kūlana, a hiki ke paipai i ka loaʻa ʻana o ka lāʻau lapaʻau ma mua o ka hoʻomaka ʻana i ka lapaʻau inā hiki.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.